• Issue

    Veterinary and Comparative Oncology: Volume 20, Issue 4

    737-905
    December 2022
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

ISSUE INFORMATION

Free Access

Issue Information

  • First Published: 09 November 2022

LETTER TO THE EDITOR

Full Access

Facilitating stakeholder involvement in Comparative Oncology research: A qualitative analysis of key stakeholder opinions and perceptions

Stephanie Marie Bollard,  Jane Howard,  Kay Curtin,  Bridget Collins,  Clodagh Canavan,  Pamela Kelly,  Amanda McCann,  Shirley M. Potter, 
  • Pages: 737-738
  • First Published: 05 October 2022

REVIEWS

Open Access

Diagnosis and histopathologic prognostication of canine melanocytic neoplasms: A consensus of the Oncology-Pathology Working Group

Rebecca C. Smedley,  Laura Bongiovanni,  Cynthia Bacmeister,  Craig A. Clifford,  Neil Christensen,  Jennifer M. Dreyfus,  Joy M. Gary,  Alana Pavuk,  Peter H. Rowland,  Christine Swanson,  Chelsea Tripp,  J. Paul Woods,  Philip J. Bergman, 
  • Pages: 739-751
  • First Published: 06 May 2022
Full Access

Local tumour nanoparticle thermal therapy: A promising immunomodulatory treatment for canine cancer

Carla Martí Castelló,  Mara Taís de Carvalho,  Andris Figueiroa Bakuzis,  Simone Gonçalves Fonseca,  Marina Pacheco Miguel, 
  • Pages: 752-766
  • First Published: 14 June 2022
Open Access

Blood biomarkers for canine cancer, from human to veterinary oncology

Philippe Colombe,  Jérémy Béguin,  Ghita Benchekroun,  Delphine Le Roux, 
  • Pages: 767-777
  • First Published: 11 July 2022

ORIGINAL ARTICLES

Full Access

Expression of the hedgehog signalling pathway and the effect of inhibition at the level of smoothened in canine osteosarcoma cell lines

Aryung Nam,  Woo-Jin Song,  Ju-Hyun An,  Robert B. Rebhun,  Hwa-Young Youn,  Kyoung-Won Seo, 
  • Pages: 778-787
  • First Published: 06 May 2022
Open Access

Combining radiation therapy with zoledronate for the treatment of osteo-invasive feline oral squamous cell carcinoma

Alycen P. Lundberg,  Christine Tran Hoang,  Audrey Billhymer,  Kim A. Selting, 
  • Pages: 788-796
  • First Published: 13 May 2022
Full Access

Lifetime prevalence of malignant and benign tumours in companion dogs: Cross-sectional analysis of Dog Aging Project baseline survey

Stephen M. Schwartz,  Silvan R. Urfer,  Michelle White,  Kate Megquier,  Sandi Shrager,  The Dog Aging Project Consortium ,  Audrey Ruple, 
  • Pages: 797-804
  • First Published: 16 May 2022
Full Access

Manipulating histone acetylation leads to antitumor effects in hemangiosarcoma cells

Tamami Suzuki,  Keisuke Aoshima,  Jumpei Yamazaki,  Atsushi Kobayashi,  Takashi Kimura, 
  • Pages: 805-816
  • First Published: 14 May 2022
Open Access

Characterizing the metabolic role of STAT3 in canine osteosarcoma

Heather L. Gardner,  Joelle M. Fenger,  Ryan D. Roberts,  Cheryl A. London, 
  • Pages: 817-824
  • First Published: 24 May 2022
Open Access

Outcome of dogs treated with chemotherapy for mesothelioma: A retrospective clinical study on 40 cases and a literature review

Mathilde Lajoinie,  Thomas Chavalle,  Franck Floch,  David Sayag,  Didier Lanore,  Frédérique Ponce,  Gabriel Chamel, 
  • Pages: 825-835
  • First Published: 28 May 2022
Open Access

Optical coherence tomography for surgical margin evaluation of excised canine cutaneous and subcutaneous tumours

Edward Cheng,  Ryan N. Jennings,  Carolyn L. Chen,  Morgan R. Biggo,  Andrea K. Erickson,  Josephine A. Dornbusch,  Sarah C. Linn,  Janis Lapsley,  Bianca M. Alva,  Joshua N. Lorbach,  Christopher Premanandan,  Laura E. Selmic, 
  • Pages: 836-845
  • First Published: 06 June 2022
Full Access

The association between symmetric dimethylarginine concentrations and various neoplasms in dogs and cats

Michael J. Coyne,  Corie Drake,  Donald J. McCrann,  David Kincaid, 
  • Pages: 846-853
  • First Published: 19 June 2022
Full Access

Multi-institutional retrospective study of canine foot pad malignant melanomas: 20 cases

Mark D. Jeon,  Haley J. Leeper,  Matthew R. Cook,  Sarah K. McMillan,  Tristram Bennett,  Caroline A. Murray,  Chelsea D. Tripp,  Kaitlin M. Curran, 
  • Pages: 854-861
  • First Published: 30 June 2022
Open Access

Allogeneic peripheral blood haematopoietic stem cell transplantation for the treatment of dogs with high-grade B-cell lymphoma

Alexandra Gareau,  Tomoko Sekiguchi,  Emma Warry,  Alexandra Z. Ripoll,  Edmund Sullivan,  Theresa Westfall,  John Chretin,  Lisa M. Fulton,  Michael Harkey,  Rainer Storb,  Steven E. Suter, 
  • Pages: 862-870
  • First Published: 04 July 2022
Full Access

Expression and therapeutic targeting of BMI1 in canine gliomas

Sami Al-Nadaf,  Kyle S. Peacott-Ricardos,  Peter J. Dickinson,  Robert B. Rebhun,  Daniel York, 
  • Pages: 871-880
  • First Published: 14 July 2022
Open Access

Inter-pathologist agreement on diagnosis, classification and grading of canine glioma

Gregory A. Krane,  Keith R. Shockley,  David E. Malarkey,  Andrew D. Miller,  C. Ryan Miller,  Debra A. Tokarz,  Heather L. Jensen,  Kyathanahalli S. Janardhan,  Matthew Breen,  Christopher L. Mariani, 
  • Pages: 881-889
  • First Published: 20 July 2022
Open Access

The mitotic regulator polo-like kinase 1 as a potential therapeutic target for c-Myc-overexpressing canine osteosarcomas

Cecilia Gola,  Luca Licenziato,  Paolo Accornero,  Selina Iussich,  Emanuela Morello,  Paolo Buracco,  Paola Modesto,  Luca Aresu,  Raffaella De Maria, 
  • Pages: 890-900
  • First Published: 05 August 2022

SHORT COMMUNICATION

Full Access

Long-term survival of dogs with stage 4 oral malignant melanoma treated with anti-canine PD-1 therapeutic antibody: A follow-up case report

Masaya Igase,  Sakuya Inanaga,  Kenji Tani,  Munekazu Nakaichi,  Yusuke Sakai,  Masashi Sakurai,  Masahiro Kato,  Toshihiro Tsukui,  Takuya Mizuno, 
  • Pages: 901-905
  • First Published: 10 May 2022